longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

KINDSTAR GLOBAL

09960

0.9250.54% ( -0.005 )
Delay Trading: Sep 15, 15:20:08
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -20.08, below the reasonable range, cheaper than 90.87% of the time in the past 5 years, and the industry ranks 21/30, the industry Median 9.15.

-20.08xP/E
HK$0.93Stock price
HK$-0.05Earnings per share
-20.08xP/E
Stock priceHK$0.93Earnings per shareHK$-0.05

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
16.48x
Typical range
-13.42x–31.57x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 9.15x
0285684112

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 9.15x
0x30x60x90x120x150x
P/E ratio
Name/Symbol
02522HKRIMAG GROUP
-72.93x519.00%HK$2.23B
09960HKKINDSTAR GLOBAL
-20.08x--HK$959.97M
02661HKQINGSONG HEALTH
-1.53x--HK$913.62M
09686HKXIKANG CLOUD
-41.85x--HK$841.88M
08037HKCH BIOTECH SER
-33.15x--HK$614.71M
02389HKBJ HEALTH
-4.68x--HK$484.70M
03869HKHOSPITAL CORP
-207.79x--HK$469.86M
01947HKMEIHAO GROUP
-22.20x--HK$351.09M
00286HKAIDIGONG
-1.30x--HK$251.76M
01406HKCLARITY MEDICAL
-6.43x--HK$191.62M
08357HKREPUBLIC HC
-3.92x--HK$80.50M
08161HKMEDINET GROUP
-6.16x--HK$19.97M
08437HKRMH HOLDINGS
-0.53x--HK$16.65M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.